Mercom Capital releases its Q3 report on funding, M&A for Digital Health

Corporate funding in Q3 2019 was down with $3.4 billion compared to $3.6 billion Q3 2018

Mercom Capital Group, recently released its report on funding and mergers and acquisitions (M&A) activity for the Digital Health (Healthcare Information Technology) sector for the third quarter (Q3) and first nine months (9M) of 2019. Mercom’s comprehensive report covers deals of all sizes from across the globe.

Global Venture Capital (VC) funding – including venture capital, private equity, and corporate venture capital – for Digital Health companies in 9M 2019 was 10 per cent lower year-over-year (YoY) with $7.2 billion in 474 deals compared to $8 billion in 556 deals in 9M 2018. In Q3 2019, Digital Health companies raised $2 billion in 156 deals compared to $3.1 billion in 173 deals in Q3 2018, a 35 per cent decline.

Digital Health companies have now received ~$42 billion in VC funding in 4,622 deals, according to Mercom.

Total corporate funding (including VC, public market, and debt financing) in 9M 2019 declined 19 per cent with $8.9 billion compared with $11 billion in 9M 2018. Total corporate funding in Q3 2019 was down slightly with $3.4 billion compared to $3.6 billion Q3 2018.

“After a strong Q2, funding and M&A activity slowed in the third quarter and financial activity is lagging compared the same period of last year. The performance of the much anticipated four digital health IPOs at the end of Q3 has been disappointing and the fate of future IPOs may depend on how well these companies fare,” said Raj Prabhu, CEO, Mercom Capital Group. “Large deals continued to dominate with six companies raising half of all the funding in the third quarter.”

Healthcare Practice-focussed companies received $599 million in 60 deals and accounted for 29 per cent of the total $2 billion VC funding in Q3 2019, compared to Q3 2018 when $1.3 billion was raised in 62 deals and accounted for 40 per cent of the total $3.1 billion VC funding. Consumer-centric companies raised $1.4 billion in 96 deals and accounted for 71 per cent of total VC funding in Q3 2019, compared to Q3 2018 when $1.9 billion was raised in 111 deals and accounted for 60 percent of the total $3.1 billion VC funding.

The top funded categories in 9M 2019 were: Telemedicine with $1.5 billion, Analytics with $1.3 billion, and mHealth Apps with $1 billion. Other Digital Health categories that received substantial funding were: Healthcare Service Booking $487 million, Mobile Wireless $437 million, and Clinical Decision Support with $425 million.

The top funded categories in Q3 2019 were: Telemedicine with $651 million, mHealth Apps with $391 million, Analytics with $201 million, Mobile Wireless with $173 million, Healthcare Service Booking with $151 million, Clinical Decision Support with $138 million, and Practice Management Solutions with $119 million.

The top Digital Health VC deals in 9M 2019 included: $550 million raised by Babylon, followed by $250 million raised by Tencent Trusted Doctors, and $205 raised by Collective Health. Capsule and Tempus brought in $200 million each.

Digital Health VC funding deals came out of twenty-one different countries in Q3 2019.

Digital Health debt and public market financing in 9M 2019 was down 40 per cent with $1.7 billion in 18 deals, compared to the $2.9 billion raised in 18 deals in 9M 2018.

There were four Digital Health IPOs in Q3 2019 in the United States raising $1.2 billion: Change Healthcare raised $557 million, followed by Livongo Health with $335 million, Health Catalyst with $182 million, and Phreesia $167 million.

In 9M 2019, there were 125 Digital Health M&A transactions compared to 172 transactions in 9M 2018. M&A activity in Q3 2019 was also down with 34 M&A transactions compared to the 56 M&A transactions in Q3 2018.

mHealth App companies were involved in the most M&A deals in 9M 2019 with 21 transactions, followed by Analytics and Practice Management Solutions with 12 and 10 transactions respectively. Clinical Decision Support and Telemedicine companies each had nine transactions. Consulting and Health Information Exchange companies each had six transactions.

Top M&A transactions in 9M 2019 included: French company Dassault Systemes’ acquisition of Medidata for an enterprise value of $5.8 billion. The EQT VIII Fund (EQT) and Canada Pension Plan Investment Board (CPPIB) acquired Waystar for $2.7 billion, followed by Golden Gate Capital, which acquired a controlling stake in Ensemble Health Partners for $1.2 billion. Baring Private Equity Asia acquired CitiusTech for more than $1 billion, Nordic Capital acquired ArisGlobal for $700 million, JP Morgan Chase acquired InstaMed for $500 million, and Thomas H Lee Partners (THL) acquired Nextech Systems for $500 million.